Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients
First Claim
1. An injectable pharmaceutical composition comprising:
- (a) at least one pharmacologically active agent in its solid phase;
(b) a vehicle essentially consisting of polyol fatty acid esters with an esterification level of over 80%; and
(c) a wetting agent comprising polyol fatty acid esters with a monoester content of over 60%,wherein the active agent is an antiparkinsonian agent which is released in the body from the injectable pharmaceutical composition in a therapeutically effective amount over a time period of at least 24 hours.
3 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to novel pharmaceutical compositions for the systemic administration of pharmacologically active ingredients. The invention relates in particular to an injectable pharmaceutical composition comprising (a) a pharmacologically active ingredient in a solid phase, (b) a vehicle consisting substantially of polyol fatty acid esters with a degree of esterification of over 80%, and (c) a wetting agent consisting substantially of polyol fatty acid esters with a monoester proportion of over 60%. The inventive composition is used for the systemic administration of numerous pharmacologically active ingredients, whereby the ingredients are released from the pharmaceutical composition over a period of at least 12, preferably at least 24 hours.
-
Citations
29 Claims
-
1. An injectable pharmaceutical composition comprising:
-
(a) at least one pharmacologically active agent in its solid phase; (b) a vehicle essentially consisting of polyol fatty acid esters with an esterification level of over 80%; and (c) a wetting agent comprising polyol fatty acid esters with a monoester content of over 60%, wherein the active agent is an antiparkinsonian agent which is released in the body from the injectable pharmaceutical composition in a therapeutically effective amount over a time period of at least 24 hours. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
Specification